Created in 2015 (United States), DTX PHARMA own 2951 sister brands and 17478 competing brands. DTX PHARMA is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. DTX PHARMA is part of the Drug Manufacturers activity sector.

DTX PHARMA is a brand of NOVARTIS N (NOVN) Share price

International deposit : 2015 Business sector Drug Manufacturers

Share price and profitability of the share NOVARTIS N (DTX PHARMA)

Buy NOVARTIS N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 94.95

Portfolio valuation
NOVARTIS N (DTX PHARMA) over 5 years* CHF 107.08

Stock market history NOVARTIS N (DTX PHARMA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
NOVARTIS N

Ataxion
Ataxion
Cadent Therapeutics
Cadent Therapeutics
Amblyotech
Amblyotech
The Medicines Company
The Medicines Company
CellforCure
CellforCure
IFM Therapeutics
IFM Therapeutics
See more brands of NOVARTIS N

Rival brands
DTX PHARMA

Fusion Pharmaceuticals
Fusion Pharmaceuticals
POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS